Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus

被引:57
作者
Lawson, Erica F. [1 ]
Trupin, Laura [2 ]
Yelin, Edward H. [2 ]
Yazdany, Jinoos [2 ]
机构
[1] Dept Pediat, Div Rheumatol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA
关键词
Systemic lupus erythematosus; Preventive care; Vaccine; Quality of care; SELF-REPORT; RISK; CARE; VALIDATION; PROVIDERS; VACCINE; MORTALITY; SERVICES; COHORT;
D O I
10.1016/j.semarthrit.2015.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To better understand why immunosuppressed individuals with systemic lupus erythematosus (SLE) fail to receive influenza and pneumococcal vaccines. Methods: These cross-sectional data were derived from the 2009 cycle of the Lupus Outcomes Study (LOS), an annual longitudinal telephone survey of individuals with confirmed SLE. Respondents were included in the analysis if they had taken immunosuppressive medications in the past year. We assessed any prior receipt of pneumococcal vaccine and influenza vaccine in the past year, and then elicited reasons for not receiving vaccination. We used bivariate statistics and multivariate logistic regression to assess frequency and predictors of reported reasons for not obtaining influenza or pneumococcal vaccines. Results: Among 508 respondents who received immunosuppressants, 485 reported whether they had received vaccines. Among the 175 respondents who did not receive an influenza vaccine, the most common reason was lack of doctor recommendation (55%), followed by efficacy or safety concerns (21%), and lack of time (19%). Reasons for not receiving pneumococcal vaccine (N = 159) were similar: lack of recommendation (87%), lack of time (7%), and efficacy or safety concerns (4%). Younger, less-educated, non-white patients with shorter disease duration, as well as those immunosuppressed with steroids alone, were at the greatest risk for not receiving indicated vaccine recommendations. Conclusions: The most common reason why individuals with SLE did not receive pneumococcal and influenza vaccines was that physicians failed to recommend them. Data suggest that increasing vaccination rates in SLE will require improved process quality at the provider level, as well as addressing patient concerns and barriers. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:666 / 671
页数:6
相关论文
共 21 条
  • [1] Mortality in systemic lupus erythematosus
    Bernatsky, S.
    Boivin, J. -F.
    Joseph, L.
    Manzi, S.
    Ginzler, E.
    Gladman, D. D.
    Urowitz, M.
    Fortin, P. R.
    Petri, M.
    Barr, S.
    Gordon, C.
    Bae, S. -C.
    Isenberg, D.
    Zoma, A.
    Aranow, C.
    Dooley, M. -A.
    Nived, O.
    Sturfelt, G.
    Steinsson, K.
    Alarcon, G.
    Senecal, J. -L.
    Zummer, M.
    Hanly, J.
    Ensworth, S.
    Pope, J.
    Edworthy, S.
    Rahman, A.
    Sibley, J.
    El-Gabalawy, H.
    McCarthy, T.
    Pierre, Y. St.
    Clarke, A.
    Ramsey-Goldman, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2550 - 2557
  • [2] Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus
    Borchers, AT
    Keen, CL
    Shoenfeld, Y
    Gershwin, ME
    [J]. AUTOIMMUNITY REVIEWS, 2004, 3 (06) : 423 - 453
  • [3] Point of care experience with pneumococcal and influenza vaccine documentation among persons aged ≥65 years: High refusal rates and missing information
    Brownfield, Elisha
    Marsden, Justin E.
    Iverson, Patty J.
    Zhao, Yumin
    Mauldin, Patrick D.
    Moran, William P.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (07) : 672 - 674
  • [4] Centers for Disease Control and Prevention, 2013, VACC REC ADV COMM IM
  • [5] Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
    Danza, A.
    Ruiz-Irastorza, G.
    [J]. LUPUS, 2013, 22 (12) : 1286 - 1294
  • [6] Delivering Influenza Vaccine to High-Risk Adults: Subspecialty Physician Practices
    Jessop, Amy B.
    Dumas, Harry
    Moser, Charlotte A.
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2013, 28 (03) : 232 - 237
  • [7] Validation of a systemic lupus activity questionnaire (SLAQ) for population studies
    Karlson, EW
    Daltroy, LH
    Rivest, C
    Ramsey-Goldman, R
    Wright, EA
    Partridge, AJ
    Liang, MH
    Fortin, PR
    [J]. LUPUS, 2003, 12 (04) : 280 - 286
  • [8] Kremers HM, 2003, J RHEUMATOL, V30, P1940
  • [9] Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections
    Luijten, R. K. M. A. C.
    Cuppen, B. V. J.
    Bijlsma, J. W. J.
    Derksen, R. H. W. M.
    [J]. LUPUS, 2014, 23 (14) : 1512 - 1516
  • [10] Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
    Mac Donald, R
    Baken, L
    Nelson, A
    Nichol, KL
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1999, 16 (03) : 173 - 177